4//SEC Filing
Roche John C 4
Accession 0001062993-25-006637
CIK 0000944695other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 4:06 PM ET
Size
15.4 KB
Accession
0001062993-25-006637
Insider Transaction Report
Form 4
Roche John C
Vice President
Transactions
- Sale
Common Stock
2025-03-28$175.03/sh−400$70,012→ 124,277.851 total - Exercise/Conversion
Common Stock
2025-03-31$77.91/sh+301$23,451→ 124,714.708 total - Exercise/Conversion
Common Stock
2025-03-28$77.91/sh+400$31,164→ 124,677.851 total - Award
Common Stock
2025-03-28+135.857→ 124,413.708 total - Sale
Common Stock
2025-03-31$175.00/sh−301$52,675→ 124,413.708 total - Exercise/Conversion
Common Stock Option (right to buy)
2025-03-28−400→ 9,207 totalExercise: $77.91Exp: 2026-02-23→ Common Stock (400 underlying) - Exercise/Conversion
Common Stock Option (right to buy)
2025-03-31−301→ 8,906 totalExercise: $77.91Exp: 2026-02-23→ Common Stock (301 underlying)
Footnotes (4)
- [F1]Exercise of options scheduled to expire in February 2026 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024.
- [F2]Does not include 14,454 shares held by the Reporting Person's spouse.
- [F3]Grant of restricted stock units ("RSUs") under the Issuer's 2022 Long-Term Incentive Plan ("2022 LTIP") in connection with the accrual of dividend equivalent rights associated with RSUs previously granted under the Issuer's 2022 LTIP. Such RSUs vest on the third anniversary of the date of grant of the original underlying RSUs.
- [F4]The option, representing the right to purchase a total of 21,413 shares, vested 1/3 on each of 2/23/17, 2/23/18 and 2/23/19.
Issuer
HANOVER INSURANCE GROUP, INC.
CIK 0000944695
Entity typeother
Related Parties
1- filerCIK 0001428157
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 4:06 PM ET
- Size
- 15.4 KB